Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This research is being done to learn more about nonmyeloablative bone marrow transplantation
(BMT), also known as a "mini" transplant for patients with blood cancers, using bone marrow
from a relative.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins